IP Verse

Agent For Reducing Adverse Side Effects Of Kinase Inhibitor

Patent No. EP2786750 (titled "Agent For Reducing Adverse Side Effects Of Kinase Inhibitor") was filed by Ajinomoto on Nov 30, 2012. The application was issued on Jun 28, 2023.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
NUTRICIAMar 7, 2017NEDERLANDSCH OCTROOIBUREAU

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2786750

AJINOMOTO
Application Number
EP12852587A
Filing Date
Nov 30, 2012
Status
Patent Maintained As Amended
May 26, 2023
Publication Date
Jun 28, 2023
External Links
Slate, Register , Google Patents